Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

View source ↗

Summary

A ClinicalTrials.gov registry entry for NCT02302742 describes a germline mutation carrier registry focused on triple-negative breast cancer and hereditary breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer, Hereditary Breast and Ovarian Cancer | Status: RECRUITING